US 11,807,611 B2
Chlorinated tetralin compounds and pharmaceutical compositions
Kristin Patterson, Stamford, CT (US); and Mark Hatcher, Stamford, CT (US)
Assigned to SPRINGWORKS THERAPEUTICS, INC., Stamford, CT (US)
Filed by SpringWorks Therapeutics, Inc., Stamford, CT (US)
Filed on Apr. 17, 2023, as Appl. No. 18/301,754.
Application 18/301,754 is a continuation of application No. PCT/US2022/076116, filed on Sep. 8, 2022.
Claims priority of provisional application 63/365,125, filed on May 20, 2022.
Claims priority of provisional application 63/263,635, filed on Nov. 5, 2021.
Claims priority of provisional application 63/241,844, filed on Sep. 8, 2021.
Prior Publication US 2023/0250065 A1, Aug. 10, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 233/88 (2006.01); A61K 31/417 (2006.01); A61K 45/06 (2006.01)
CPC C07D 233/88 (2013.01) [A61K 31/417 (2013.01); A61K 45/06 (2013.01)] 19 Claims
 
1. A method of treating a desmoid tumor in a patient in need thereof comprising administering to the patient a pharmaceutical composition comprising a compound of Formula IC

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.